CureVac to cut costs, starts GSK-partnered bird flu vaccine trial

Lei Lei Wu

News Reporter

CureVac, once a player in the Covid-19 vaccine race, announced that it plans to reduce costs across the company.

It said Wednesday that it enacted in March a program for employees to voluntarily leave the company, with a goal of cutting 150 positions from its workforce. The news was first reported last month by German news outlet SWR. CureVac currently has more than 1,100 employees, according to the annual report.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

CureVac to cut costs, starts GSK-partnered bird flu vaccine trial

Lei Lei Wu

News Reporter

Unlock this article instantly by becoming a free subscriber.

House to mark up bill targeting Chinese biotech and genomics companies

Amgen touts new data for obesity drug MariTide, moving rapidly into Phase 3 work

J&J showcases more bladder cancer results from 'pretzel' drug-device combo

AbbVie puts $161M into new R&D site in Germany, will add 300 jobs

BridgeBio spins out oncology unit with $200M in backing for RAS assets

A New Precision Approach for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Cure­Vac to cut costs, starts GSK-part­nered bird flu vac­cine tri­al

Lei Lei Wu

News Reporter

Unlock this article instantly by becoming a free subscriber.

House to mark up bill tar­get­ing Chi­nese biotech and ge­nomics com­pa­nies

Am­gen touts new da­ta for obe­si­ty drug Mar­i­Tide, mov­ing rapid­ly in­to Phase 3 work

J&J show­cas­es more blad­der can­cer re­sults from 'pret­zel' drug-de­vice com­bo

Ab­b­Vie puts $161M in­to new R&D site in Ger­many, will add 300 jobs

Bridge­Bio spins out on­col­o­gy unit with $200M in back­ing for RAS as­sets

A New Pre­ci­sion Ap­proach for Non-Small Cell Lung Can­cer with EGFR Ex­on 20 In­ser­tion Mu­ta­tions

CureVac to cut costs, starts GSK-partnered bird flu vaccine trial

House to mark up bill targeting Chinese biotech and genomics companies

Amgen touts new data for obesity drug MariTide, moving rapidly into Phase 3 work

J&J showcases more bladder cancer results from 'pretzel' drug-device combo

AbbVie puts $161M into new R&D site in Germany, will add 300 jobs

BridgeBio spins out oncology unit with $200M in backing for RAS assets

A New Precision Approach for Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations